Prescription Use Blood Glucose Meter For Near-Patient Testing
The Prescription Use Blood Glucose Meter For Near-Patient Testing is an in vitro diagnostic device intended for multiple-patient quantitative glucose determination across all hospital and professional healthcare settings, used for the identification and management of dysglycemia. It is classified as a Class 2 device under regulation 862.1345, requiring 510(k) premarket notification before marketing. The product code is PZI, and it falls within the Clinical Chemistry (CH) medical specialty. It is not an implant and is not life-sustaining.
Research product code PZI in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- PZI
- Device Class
- FDA class 2
- Regulation Number
- 862.1345
- Medical Specialty
- Clinical Chemistry
- Review Panel
- CH
- Submission Type
- 1
Device Characteristics
Definition
Intended for use in near-patient testing settings for in vitro diagnostic, multiple-patient use for the quantitative determination of glucose throughout all hospital and all professional healthcare settings for use in determining dysglycemia.
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 14 510(k) clearances via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K252323 | cobas pulse blood glucose monitoring system | Jun 12, 2026 | Substantially Equivalent | Roche Diagnostics |
| K221349 | XPER Technology PREMIUM Pro Blood Glucose Monitoring System | Nov 19, 2024 | Substantially Equivalent | Taidoc Technology Corporation |
| K220272 | cobas pulse blood glucose monitoring system | Apr 26, 2024 | Substantially Equivalent | Roche Diagnostics |
| K232075 | StatStrip Glucose Hospital Meter System | Feb 23, 2024 | Substantially Equivalent | Nova Biomedical Corporation |
| K200788 | Assure Titanium Blood Glucose Monitoring System | May 23, 2022 | Substantially Equivalent | Arkray, Inc. |
| K182552 | StatStrip Xpress Glucose Hospital Meter System | Dec 13, 2018 | Substantially Equivalent | Nova Biomedical Corporation |
| K182549 | StatStrip Xpress 2 Glucose Hospital Meter System | Dec 13, 2018 | Substantially Equivalent | Nova Biomedical Corporation |
| K181043 | StatStrip Glucose Hospital Meter System | Jul 12, 2018 | Substantially Equivalent | Nova Biomedical Corporation |
| K163490 | StatStrip Xpress 2 Glucose Hospital Meter System | Jan 06, 2017 | Substantially Equivalent | Nova Biomedical Corporation |
| K161856 | StatStrip Xpress Glucose Hospital Meter System | Nov 15, 2016 | Substantially Equivalent | Nova Biomedical Corporation |
| K152986 | StatStrip Xpress 2 Glucose Hospital Meter System | Jan 27, 2016 | Substantially Equivalent | Nova Biomedical Corporation |
| K150461 | StatStrip Xpress Glucose Hospital Meter System | May 20, 2015 | Substantially Equivalent | Nova Biomedical Corporation |
| K150281 | StatStrip Glucose Hospital Meter | May 06, 2015 | Substantially Equivalent | Nova Biomedical Corporation |
| K132121 | STATSTRIP GLUCOSE HOSPITAL METER SYSTEM | Sep 24, 2014 | Substantially Equivalent | Nova Biomedical Corporation |
FEI Numbers
This FDA classification entry is associated with 8 FEI numbers. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 8 registration numbers. Click on an entry to view related FDA registrations.